Quick Search:

uzh logo
Browse by:

Zurich Open Repository and Archive 

van der Leest, R J T; de Vries, E; Bulliard, J-L; Paoli, J; Peris, K; Stratigos, A J; Trakatelli, M; Maselis, T J E M L; Situm, M; Pallouras, A C; Hercogova, J; Zafirovik, Z; Reusch, M; Olah, J; Bylaite, M; Dittmar, H C; Scerri, L; Correia, O; Medenica, L; Bartenjev, I; Guillen, C; Cozzio, A; Bogomolets, O V; del Marmol, V (2011). The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010. Journal of the European Academy of Dermatology and Venereology, 25(12):1455-1465.

Full text not available from this repository.


Background: Euromelanoma is a skin cancer education and prevention campaign that started in 1999 in Belgium as ‘Melanoma day’. Since 2000, it is active in a large and growing number of European countries under the name Euromelanoma.

Objective: To evaluate results of Euromelanoma in 2009 and 2010 in 20 countries, describing characteristics of screenees, rates of clinically suspicious lesions for skin cancer and detection rates of melanomas.

Methods: Euromelanoma questionnaires were used by 20 countries providing their data in a standardized database (Belgium, Croatia, Cyprus, Czech Republic, FYRO Macedonia, Germany, Greece, Hungary, Italy, Lithuania, Luxembourg, Malta, Moldavia, Portugal, Serbia, Slovenia, Spain, Sweden, Switzerland and Ukraine).

Results: In total, 59 858 subjects were screened in 20 countries. Most screenees were female (64%), median ages were 43 (female) and 46 (male) and 33% had phototype I or II. The suspicion rates ranged from 1.1% to 19.4% for melanoma (average 2.8%), from 0.0% to 10.7% for basal cell carcinoma (average 3.1%) and from 0.0% to 1.8% for squamous cell carcinoma (average 0.4%). The overall positive predictive value of countries where (estimation of) positive predictive value could be determined was 13.0%, melanoma detection rates varied from 0.1% to 1.9%. Dermoscopy was used in 78% of examinations with clinically suspected melanoma; full body skin examination was performed in 72% of the screenees.

Conclusion: Although the population screened during Euromelanoma was relatively young, high rates of clinically suspected melanoma were found. The efficacy of Euromelanoma could be improved by targeting high-risk populations and by better use of dermoscopy and full body skin examination

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Dermatology Clinic
DDC:610 Medicine & health
Deposited On:15 Mar 2012 09:34
Last Modified:28 Nov 2013 00:24
Publisher DOI:10.1111/j.1468-3083.2011.04228.x
PubMed ID:21951235
Citations:Web of Science®. Times Cited: 13
Google Scholar™

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page